<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T14:46:06Z</responseDate>
  <request identifier="oai:figshare.com:article/34027029" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34027029</identifier>
        <datestamp>2026-09-29T17:40:29Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_8</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_39</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Clinical course of SUDV-infected IFNAR&lt;sup&gt;-/-&lt;/sup&gt; mice.&lt;/p&gt;</dc:title>
          <dc:creator>Michelle Gellhorn Serra (25138177)</dc:creator>
          <dc:creator>Cornelius Rohde (7356083)</dc:creator>
          <dc:creator>Lucie Sauerhering (6646112)</dc:creator>
          <dc:creator>Lars Meier (9179480)</dc:creator>
          <dc:creator>Lennart Kämper (11608114)</dc:creator>
          <dc:creator>Pauline Neubecker (23778913)</dc:creator>
          <dc:creator>Markus Eickmann (288210)</dc:creator>
          <dc:creator>Alexandra Kupke (4603690)</dc:creator>
          <dc:creator>Stephan Becker (146493)</dc:creator>
          <dc:creator>Anke-Dorothee Werner (16660476)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Ecology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>widespread systemic dissemination</dc:subject>
          <dc:subject>viral genome copies</dc:subject>
          <dc:subject>systemic viral dissemination</dc:subject>
          <dc:subject>sup &gt;-/-&lt;/ sup</dc:subject>
          <dc:subject>suitable animal models</dc:subject>
          <dc:subject>substantial weight loss</dc:subject>
          <dc:subject>significantly elevated concentrations</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>associated immune responses</dc:subject>
          <dc:subject>post mortem &lt;/</dc:subject>
          <dc:subject>key inflammatory features</dc:subject>
          <dc:subject>inflammatory responses described</dc:subject>
          <dc:subject>investigating filovirus pathogenesis</dc:subject>
          <dc:subject>requires preclinical evaluation</dc:subject>
          <dc:subject>pronounced inflammatory response</dc:subject>
          <dc:subject>lethal sudv infection</dc:subject>
          <dc:subject>pronounced changes</dc:subject>
          <dc:subject>preclinical studies</dc:subject>
          <dc:subject>filoviridae &lt;/</dc:subject>
          <dc:subject>filovirus infections</dc:subject>
          <dc:subject>filovirus disease</dc:subject>
          <dc:subject>tissue pathology</dc:subject>
          <dc:subject>therapeutic antibodies</dc:subject>
          <dc:subject>tested organs</dc:subject>
          <dc:subject>sudv infection</dc:subject>
          <dc:subject>sudan virus</dc:subject>
          <dc:subject>potential limitation</dc:subject>
          <dc:subject>observed cytokine</dc:subject>
          <dc:subject>multiple cytokines</dc:subject>
          <dc:subject>medical countermeasures</dc:subject>
          <dc:subject>mechanistic basis</dc:subject>
          <dc:subject>infected controls</dc:subject>
          <dc:subject>including antivirals</dc:subject>
          <dc:subject>hematopoietic mediators</dc:subject>
          <dc:subject>following infection</dc:subject>
          <dc:subject>findings characterize</dc:subject>
          <dc:subject>encompassing pro</dc:subject>
          <dc:subject>data support</dc:subject>
          <dc:subject>chemokines compared</dc:subject>
          <dc:subject>chemokine elevations</dc:subject>
          <dc:description>&lt;p&gt;The experimental approach is shown in &lt;b&gt;(A)&lt;/b&gt;. Female (F) and male (M) IFNAR&lt;sup&gt;-/-&lt;/sup&gt; mice were infected with approx. 1,000 PFU SUDV on day 0 (n = 6) and monitored daily. The mice were euthanized at humane clinical endpoint (score of ≥10 on one day or ≥6 on two consecutive days). Blood samples were collected at day 3, and on the day of euthanasia. The additive clinical score &lt;b&gt;(B)&lt;/b&gt;, summarizes the results of the different parameters analyzed daily: (C) body weight, behaviour, and appearance. Each parameter could be awarded a maximum of 10 points. Grey boxes indicate days after euthanasia. The relative body weight compared to day 0 for each mouse is depicted in &lt;b&gt;(D)&lt;/b&gt;. The dotted line marks the clinical endpoint. The Kaplan-Meier survival curve &lt;b&gt;(E)&lt;/b&gt; depicts the percentage of surviving mice over time.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-29T17:40:18Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pone.0347080.g001</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Clinical_course_of_SUDV-infected_IFNAR_sup_-_-_sup_mice_p_/34027029</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
